Elopag 25 (Eltrombopag) 25 mg Tablets
Elopag 25 mg (Eltrombopag) is a thrombopoietin receptor agonist used to stimulate platelet production in certain blood disorders.
Manufacturer: Everest Pharmaceuticals Ltd.. Each pack contains 14 tablets. The drug helps increase platelet counts in patients with chronic immune thrombocytopenia and other conditions associated with thrombocytopenia.
Key Feature:
Eltrombopag stimulates platelet production in the bone marrow and may reduce the risk of bleeding in patients who have had an insufficient response to standard therapy.
Indicated for adult patients and, in some cases, pediatric patients as prescribed by a physician for the following conditions:
- 🔹 Chronic Immune Thrombocytopenia (ITP): in patients with insufficient response to corticosteroids, immunoglobulins, or splenectomy.
- 🔹 Thrombocytopenia associated with chronic hepatitis C: to allow initiation and maintenance of antiviral therapy.
- 🔹 Severe Aplastic Anemia: in patients with inadequate response to immunosuppressive therapy.
Packaging: 25 mg tablets.
⚠️ ADMINISTRATION PROTOCOL:
- Starting Dose: Determined individually by the physician depending on indication, platelet count, and patient condition.
- Food Intake: Take on an empty stomach or with a meal low in calcium.
- Important: Do not take together with dairy products, antacids, or products containing calcium, magnesium, aluminum, iron, selenium, or zinc. A gap of at least 4 hours is recommended.
- Monitoring: Regular monitoring of platelet count, liver function, and complete blood count is required.
- Note: Dose adjustments should only be made by the treating physician based on laboratory results.
- Hypersensitivity to Eltrombopag or any component of the product.
- Use with caution in severe hepatic impairment.
- Risk of thromboembolic complications.
- Pregnancy and breastfeeding — only if clearly prescribed by a physician when benefits outweigh risks.
Common and clinically important adverse reactions include:
- 🩸 Blood/Vascular: Risk of thrombosis and thromboembolism if platelet counts rise excessively.
- 📉 Gastrointestinal: Nausea, diarrhea, abdominal pain, decreased appetite.
- 🧪 Liver: Elevated liver enzymes, hepatotoxicity.
- 💢 General: Headache, weakness, fatigue.
- 👁 Other: Possible cataract progression with long-term use.
Similar products
What Customers Say
No reviews yet
Your review can be the first!